• Perifosine (KRX-0401): Applied Workflows for Akt Pathway Inh

  2026-06-03

  Perifosine (KRX-0401) is a synthetic Akt inhibitor optimized for apoptosis and radiosensitization studies. This article translates recent mechanistic insights and experimental workflows into actionable protocols for cancer and neuroprotection research, with practical troubleshooting tips and cross-domain context.

• Microneedle Patch Delivery of Risedronate Sodium for Osteopo

  2026-06-03

  This study introduces a dissolving microneedle patch that delivers Risedronate Sodium and Ursolic Acid via bipartite nanotransfersomes for osteoporosis management. The approach addresses bioavailability barriers, demonstrating efficient drug encapsulation and sustained release, with potential to improve therapeutic outcomes in bone metabolism research.

• MG-132 (Z-LLL-al): Strategic Proteasome Inhibition for Trans

  2026-06-02

  Explore how MG-132 (Z-LLL-al) redefines translational research through precise ubiquitin-proteasome system inhibition. This article delivers a mechanistic deep-dive into apoptosis and cell cycle regulation, synthesizing recent breakthroughs—including caspase-driven autophagy and stress adaptation—with APExBIO’s trusted reagent. Strategic guidance on experimental design, competitive positioning, and protocol parameters empowers researchers to bridge discovery with impactful clinical insights.

• ATRX Deficiency Sensitizes Glioma Cells to RTK and PDGFR Inh

  2026-06-02

  This study demonstrates that ATRX-deficient high-grade glioma cells are significantly more sensitive to multi-targeted RTK and PDGFR inhibitors than ATRX-proficient counterparts. The findings suggest that ATRX mutation status should be considered in the design and interpretation of targeted therapy trials for aggressive gliomas.

• Neticonazole Hydrochloride: Imidazole Antifungal in Cancer R

  2026-06-01

  Neticonazole Hydrochloride stands apart as a dual-action imidazole antifungal with validated roles in both superficial infection control and colorectal cancer research. Its unique mechanism—combining membrane synthesis inhibition and exosome pathway suppression—makes it indispensable for translational workflows seeking robust, reproducible outcomes.

• Sulfo-NHS-LC-Biotin: Technical Guide for Cell Surface Biotin

  2026-06-01

  Sulfo-NHS-LC-Biotin enables selective, covalent labeling of primary amines on cell surface proteins and peptides in aqueous settings, providing stable biotin tags for downstream detection or purification. It is not suitable for intracellular or reversible biotinylation workflows due to its membrane impermeability and irreversible bond formation.

• Caspofungin in Translational Antifungal Research: Mechanisms

  2026-05-31

  This thought-leadership article explores how Caspofungin, a lipopeptide antifungal drug, enables advanced translational research against azole-resistant Candida species. It synthesizes mechanistic insight, strategic workflow guidance, and competitive context, providing actionable recommendations for researchers aiming to bridge basic science and clinical application.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-05-30

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) offers clear, color-coded molecular weight standards for SDS-PAGE and Western blot workflows, supporting visual monitoring and size verification across 10–250 kDa. It is not suitable for native PAGE or assays requiring preserved enzymatic activity, and is specifically designed for compatibility with phosphoprotein detection and fluorescent imaging.

• Sulfo-NHS-SS-Biotin: Precision Protein Labeling for Affinity

  2026-05-29

  Sulfo-NHS-SS-Biotin offers unmatched specificity and reversibility for cell surface protein labeling and affinity purification, thanks to its water-soluble, cleavable design. This article unpacks advanced workflows, troubleshooting, and optimization strategies that leverage this biotin disulfide N-hydroxysulfosuccinimide ester, bridging cutting-edge research to reproducible lab practice.

• Cell Surface GlycoRNA–RBP Clusters Enable Peptide Entry: New

  2026-05-29

  This study uncovers that RNA binding proteins (RBPs) and glycoRNAs form organized nanoclusters on the cell surface, serving as entry domains for cell-penetrating peptides. The findings revise our understanding of cell surface composition and highlight new molecular targets for cell entry and communication.

• Hematoxylin and Eosin Staining Kit: Protocol Precision and C

  2026-05-28

  Explore the Hematoxylin and Eosin staining kit for advanced tissue morphology visualization. This article offers a deep dive into staining mechanisms, assay decision-making, and cross-disciplinary applications, providing scientific context beyond standard workflows.

• Biotin-Tyramide: Mechanistic Excellence in Translational Det

  2026-05-28

  Discover how biotin-tyramide enables ultrasensitive, spatially resolved detection in immunohistochemistry and aptamer-based diagnostics. This thought-leadership article integrates mechanistic insight, protocol strategy, and the latest scientific advances, offering translational researchers actionable guidance for maximizing signal amplification and specificity in complex biological contexts.

• Ibrexafungerp and Caspofungin Against Fluconazole-Resistant

  2026-05-27

  Wiederhold et al. present robust preclinical evidence that ibrexafungerp, a novel triterpenoid, and caspofungin, a lipopeptide antifungal drug, both significantly reduce fungal burden and improve survival in a murine model of invasive candidiasis caused by fluconazole-resistant Candida auris. This work highlights the continued importance of targeting β-(1,3)-D-glucan biosynthesis in antifungal agent development against multidrug-resistant strains.

• Dabigatran (Pradaxa): Precision Workflows for Thrombin Inhib

  2026-05-27

  Dabigatran (Pradaxa) empowers researchers with reproducible, high-specificity thrombin inhibition workflows for advanced coagulation studies and translational models. This guide details optimized protocols, troubleshooting strategies, and unique comparative advantages that set APExBIO’s Dabigatran apart in anticoagulation research.

• Dabigatran (Pradaxa): Precision Tools for Thrombin Inhibitio

  2026-05-26

  Dabigatran empowers researchers with precise, reversible thrombin inhibition, streamlining coagulation function tests for both basic and translational studies. This guide unpacks experimental workflows, troubleshooting strategies, and protocol enhancements to maximize the reliability and reproducibility of your anticoagulation research.

16787 records 1/1120 page Next 12345 下5页 Last page